Filter
301
Text search:
vaccine
trial
Featured
Recommendations
32
New Publications
48
Language
Document type
No document type
129
Studies & Reports
59
Guidelines
56
Fact sheets
14
Manuals
11
Strategic & Response Plan
10
Training Material
7
Situation Updates
7
Resource Platforms
6
App
1
Infographics
1
Countries / Regions
Global
14
Kenya
8
India
6
East and Southern Africa
6
West and Central Africa
6
Eastern Europe
6
Russia
6
Uganda
5
South Africa
5
Brazil
5
Africa
5
Sierra Leone
4
Liberia
4
Nigeria
4
Zimbabwe
4
Middle East and North Africa
4
Western and Central Europe
4
Bangladesh
3
Latin America and the Carribbean
3
Ghana
2
South Sudan
2
Zambia
2
Cambodia
2
Malawi
2
Ukraine
2
Guinea
1
Congo, Democratic Republic of
1
Ethiopia
1
Philippines
1
Nepal
1
Syria
1
Tanzania
1
Rwanda
1
Indonesia
1
Mozambique
1
Papua New Guinea
1
Sudan
1
Honduras
1
Ecuador
1
Lesotho
1
Myanmar / Burma
1
Chile
1
Yemen
1
South–East Asia Region
1
Western Pacific Region
1
Asia
1
Venezuela
1
Southern Africa
1
Laos
1
Vietnam
1
Authors & Publishers
Publication Years
Category
Countries
74
Clinical Guidelines
37
Women & Child Health
23
Public Health
13
Key Resources
7
Pharmacy & Technologies
2
Toolboxes
COVID-19
77
TB
34
HIV
27
NTDs
23
Ebola & Marburg
10
AMR
9
Rapid Response
8
Mental Health
6
Pharmacy
6
Polio
5
Global Health Education
4
Planetary Health
4
NCDs
4
Zika
3
Malaria
2
Disability
1
Cholera
1
Conflict
1
Refugee
1
Caregiver
1
2.0 Rapid Response
1
In the current absence of vaccine for COVID-19, public health response target breaking the chain of infection by focusing on the mode of transmission. This paper summarizes current evidence-base around the transmission dynamics, pathogenic, and clin
...
Interim recommendations for the use of ChAdOx1-S [recombinant] COVID-19 vaccine (AstraZeneca COVID-19 AZD1222 Vaxzevria™, SII COVISHIELD™ vaccine) - Last updated 30 July 2021
When situations occur in which unwanted events are rightly or wrongly connected with vaccination, they may erode confidence in vaccines and the authorities delivering them. This document presents the scientific evidence behind WHO’s recommendations on building and restoring confidence in vaccines
...
Sleeping sickness is controlled by case detection and treatment but this often only reaches less than 75% of the population. Vector control is capable of completely interrupting HAT transmission but is not used because of expense. We conducted a full scale field
...
The position papers are intended for use by national public health officials and managers of immunization programmes. They may also be of interest to international funding agencies, vaccine advisory groups,
...
This global guidance provided the framework for over 100 countries to develop their NDVPs. This updated (second) version supersedes the previous version published in 16 November 2020. New information has been added on the following areas:
the COVID-19 Partners Platform;
the use of COVID
...
“Guide to facilitate the implementation of the WHO/UNICEF “Guidance on developing a national deployment and vaccination plan for COVID-19 vaccines” for Africa
t contains action-oriented lists of critical topics to address and checklists tailored to the context of African Union Member States.
...
The Lancet Volume 390, Issue 10110p2397-2409November 25, 2017.
Human African trypanosomiasis (HAT), also called sleeping sickness, is a parasitic infection that almost invariably progresses to death, unless treatment is provided. HAT caused devastating epidemics during the 20th century. Thanks to
...
This report is one of the first major products of the newly established Precision Public Health Metrics unit of the UCN cluster of the WHO Regional Office for Africa. The report presents national trends in communicable and non-communicable disease burden and control in the WHO African region. It tra
...
Taking the whole of Africa approach to fighting the COVID-19 pandemic has and will continue to require coordinated efforts from multiple stakeholders from across the continent. Africa CDC would like to acknowledge the deep partnership and continued support of AUDA-NEPAD, AVAREF, WHO AFRO, the Bill a
...
In this document, recommendations are provided on designing and implementing
a cross-sectional serosurvey using school-based sampling to estimate age-specific
DENV seroprevalence to inform a country’s national dengue vaccination program.
The document includes recommendations for methods for
...
The technical note from the Global Task Force on Cholera Control (GTFCC) examines the risks and benefits of vaccinating pregnant women with WHO-prequalified oral cholera vaccines (OCVs) during mass vaccination campaigns. It highlights that three WHO-approved vaccines (Dukoral®, Shanchol™, and Euv
...
Epidemics of infectious diseases are occurring more often, and spreading faster and further than ever, in many different regions of the world. The background factors of this threat are biological, environmental and lifestyle changes, among others. A potentially fatal combination of newly-discovered
...
Polio vaccines: WHO position paper – June 2022
recommended
This position paper on polio vaccines replaces the 2016 WHO position paper, and summarizes recent developments in the field.
The goal of the strategy is to prevent seasonal influenza, control the spread of influenza from animals to humans, and prepare for the next influenza pandemic.
The new strategy is the most comprehensive and far-reaching that WHO has ever developed for influenza. It outlines a path to protect popul
...
Clinical Infectious Diseases 2010; 50:291–322
The report presents current information (updated to September 2015) on candidate vaccines, therapies and medical devices for Ebola and gives an overview of completed and on-going trials.
This document provides answers to FAQs healthcare providers and staff may have about COVID-19 vaccines
